Warnings, Columns-Drugs & Supplements, June 2005
June 8, 2005
FDA Advises Consumers About Recalled Drugs from Able Laboratories WASHINGTON, D.C. - The Food and Drug Administration is advising the public that Able Laboratories of Cranbury, N.J., is conducting a nationwide recall of all of its manufactured drugs because of quality control concerns. The company manufactures mostly generic prescription drugs, including drugs containing acetaminophen. Able Laboratories has ceased all current production, according to the FDA. The FDA said that Able products that are being recalled can be identified by the lot numbers printed on their packaging, and a list of the recalled drugs and …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation ConferenceJanuary 10, 2025 - Long Beach, CA
The Westin Long Beach
|
